Pharmacology of fusaric acid in man

The effect of speed-accuracy strategy on response interference control in Parkinson's disease.

Neuropsychologia·2009

Autosomal dominant subcortical gliosis presenting as frontotemporal dementia.

Neurology·2009

The effect of Parkinson's disease on interference control during action selection.

Neuropsychologia·2008

Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.

Neurology·2008

Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study.

Neurology·2006

Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs.

Neurology·2006

Exposure-Response Analyses of Datopotamab Deruxtecan (Dato-DXd), a TROP2-Directed Antibody-Drug Conjugate, in Advanced Non-small Cell Lung Cancer.

Clinical pharmacology and therapeutics·2026

Exposure-Response Analysis of Enfortumab Vedotin Plus Pembrolizumab as First-Line Therapy for Locally Advanced or Metastatic Urothelial Cancer.

Clinical pharmacology and therapeutics·2026

How to Optimize Healthy Volunteer Screening and Enrolment in Clinical Trials: A Qualitative and Quantitative Approach to Evaluate Processes and Healthy Volunteers' Perceptions.

Clinical pharmacology and therapeutics·2026

Phase I Evaluation of Siltartoxatug, a First-in-Class Anti-Tetanus Monoclonal Antibody: Safety, Pharmacokinetics and Pharmacodynamics in Healthy Australian and Chinese Populations.

Clinical pharmacology and therapeutics·2026

Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma.

Clinical pharmacology and therapeutics·2026

Toward Fit-for-Purpose Data for Drug Assessment in Non-small Cell Lung Cancer: A Core Dataset.

Clinical pharmacology and therapeutics·2026

Japanese subgroup analysis of AQUILA trial: daratumumab vs active monitoring in high-risk smoldering multiple myeloma.

Japanese journal of clinical oncology·2026

Safety and Efficacy of Nanomicellar 0.09% Cyclosporine for Treatment of Dry Eye Disease Refractory to 0.05% Cyclosporine Emulsion: A Single-Arm Prospective Switch Study.

Cornea·2026

Suspected Xylazine-Associated Skin Ulcers in Montreal, Canada: A Case Report on Diagnostic Challenges and Multidisciplinary Care.

Cureus·2026

[Diagnosis and Management of Patients with Migraines and Other Headaches].

Brain and nerve = Shinkei kenkyu no shinpo·2026

Development of an AAV-Encoded Adenine Base Editor for Duchenne Muscular Dystrophy.

Human gene therapy·2026

Roflumilast Cream for Residual Disease in Patients With Atopic Dermatitis on Dupilumab: A Retrospective Chart Review Study.

Dermatology and therapy·2026

Related Experiment Videos

Pharmacology of fusaric acid in man

Related Concept Videos

The effect of speed-accuracy strategy on response interference control in Parkinson's disease.

Autosomal dominant subcortical gliosis presenting as frontotemporal dementia.

The effect of Parkinson's disease on interference control during action selection.

Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.

Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study.

Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs.

Exposure-Response Analyses of Datopotamab Deruxtecan (Dato-DXd), a TROP2-Directed Antibody-Drug Conjugate, in Advanced Non-small Cell Lung Cancer.

Exposure-Response Analysis of Enfortumab Vedotin Plus Pembrolizumab as First-Line Therapy for Locally Advanced or Metastatic Urothelial Cancer.

How to Optimize Healthy Volunteer Screening and Enrolment in Clinical Trials: A Qualitative and Quantitative Approach to Evaluate Processes and Healthy Volunteers' Perceptions.

Phase I Evaluation of Siltartoxatug, a First-in-Class Anti-Tetanus Monoclonal Antibody: Safety, Pharmacokinetics and Pharmacodynamics in Healthy Australian and Chinese Populations.

Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma.

Toward Fit-for-Purpose Data for Drug Assessment in Non-small Cell Lung Cancer: A Core Dataset.

Japanese subgroup analysis of AQUILA trial: daratumumab vs active monitoring in high-risk smoldering multiple myeloma.

Safety and Efficacy of Nanomicellar 0.09% Cyclosporine for Treatment of Dry Eye Disease Refractory to 0.05% Cyclosporine Emulsion: A Single-Arm Prospective Switch Study.

Suspected Xylazine-Associated Skin Ulcers in Montreal, Canada: A Case Report on Diagnostic Challenges and Multidisciplinary Care.

[Diagnosis and Management of Patients with Migraines and Other Headaches].

Development of an AAV-Encoded Adenine Base Editor for Duchenne Muscular Dystrophy.

Roflumilast Cream for Residual Disease in Patients With Atopic Dermatitis on Dupilumab: A Retrospective Chart Review Study.

Related Experiment Videos

Pharmacology of fusaric acid in man

Related Concept Videos

Related Articles